Martyn Jacobs
Stock Analyst at Bell Potter
(0.06)
# 4,650
Out of 4,676 analysts
198
Total ratings
23.2%
Success rate
-15.6%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.60 → $3.15 | $2.37 | +33.19% | 9 | Aug 26, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Maintained: Buy | $3.15 | $1.75 | +80.52% | 10 | Aug 25, 2026 | |
| ASX: MVP Medical Developments International Limited | Maintained: Buy | $1.00 | $0.53 | +90.48% | 16 | Aug 24, 2026 | |
| ASX: AYA Artrya Limited | Maintained: Buy | $6.10 → $6.75 | $4.66 | +44.85% | 5 | Aug 20, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Buy | $28.75 → $27.50 | $20.17 | +36.34% | 7 | Aug 20, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $0.90 → $0.70 | $0.30 | +135.69% | 20 | Aug 13, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Maintained: Buy | $5.15 | $3.80 | +35.53% | 12 | Aug 5, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Maintained: Buy | $0.45 → $0.42 | $0.16 | +162.50% | 10 | Jul 30, 2026 | |
| ASX: BIO Biome Australia Limited | Maintained: Buy | $0.75 | $0.28 | +167.86% | 19 | Jul 30, 2026 | |
| ASX: IPD ImpediMed Limited | Maintained: Buy | $0.01 | $0.01 | +100.00% | 15 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.25 | $0.10 | +145.10% | 3 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.75 → $0.77 | $0.71 | +9.22% | 8 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.55 → $0.45 | $0.23 | +95.65% | 4 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.05 → $0.75 | $0.19 | +294.74% | 15 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.19 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.011 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.88 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.058 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.017 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.094 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.055 | n/a | 2 | Oct 31, 2022 |
Integral Diagnostics Limited
Aug 26, 2026
Maintained: Buy
Price Target: $3.60 → $3.15
Current: $2.37
Upside: +33.19%
EMVision Medical Devices Ltd
Aug 25, 2026
Maintained: Buy
Price Target: $3.15
Current: $1.75
Upside: +80.52%
Medical Developments International Limited
Aug 24, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.53
Upside: +90.48%
Artrya Limited
Aug 20, 2026
Maintained: Buy
Price Target: $6.10 → $6.75
Current: $4.66
Upside: +44.85%
Sonic Healthcare Limited
Aug 20, 2026
Maintained: Buy
Price Target: $28.75 → $27.50
Current: $20.17
Upside: +36.34%
EBR Systems, Inc.
Aug 13, 2026
Maintained: Buy
Price Target: $0.90 → $0.70
Current: $0.30
Upside: +135.69%
Vitrafy Life Sciences Limited
Aug 5, 2026
Maintained: Buy
Price Target: $5.15
Current: $3.80
Upside: +35.53%
Oneview Healthcare PLC
Jul 30, 2026
Maintained: Buy
Price Target: $0.45 → $0.42
Current: $0.16
Upside: +162.50%
Biome Australia Limited
Jul 30, 2026
Maintained: Buy
Price Target: $0.75
Current: $0.28
Upside: +167.86%
ImpediMed Limited
Jul 29, 2026
Maintained: Buy
Price Target: $0.01
Current: $0.01
Upside: +100.00%
Jul 28, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.10
Upside: +145.10%
Jul 21, 2026
Maintained: Hold
Price Target: $0.75 → $0.77
Current: $0.71
Upside: +9.22%
Jun 1, 2026
Maintained: Buy
Price Target: $0.55 → $0.45
Current: $0.23
Upside: +95.65%
May 27, 2026
Maintained: Buy
Price Target: $1.05 → $0.75
Current: $0.19
Upside: +294.74%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.19
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.011
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.88
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.058
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.017
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.094
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.055
Upside: n/a